Table 3.

Presenting features, initial IgG4 levels, treatment, and follow up PET/CT findings

Patient no.	Presenting features	IgG4 levels at the time of diagnosis (mg/dL)	Latest subsequent IgG4 levels (mg/dL)	Initial prednisolone dose or any other medication	Current prednisolone dose or any other medication	Follow-up scan findings
1	Loss of weight, fatigue	269	340 (4 years post diagnosis)	50 mg OM	7.5 mg OM	Abnormal (4 years post diagnosis)
2	Paraproteinaemia, loss of weight, altered bowel habits	22	159 (3 years post diagnosis)	30 mg BD; Rituximab; Mycofenolate mofeteil 1 g BD	5 mg OM	Normal (3 years post diagnosis)
3	Enlargement of salivary glands and loss of weight	51	193 (1 year post diagnosis)	80 mg OM	5 mg OM; mycofenolate mofeteil 1 g BD	Normal (1 year post diagnosis)
4	Chest pain	149	158 (1 year post diagnosis)	30 mg OM; Methotrexate 20 mg once/week	3 mg OM; methotrexate 15 mg once/week	Normal (2 years post diagnosis)
5	Bilateral lacrimal gland enlargement	269	340 (1 year post diagnosis)	Nil	Nil	N/A
6	Obstructive jaundice	233	340 (5 months post diagnosis)	2 mg 4 times/week; Azathioprine 100 mg OM	5 mg OM; azathioprine 150 mg OM	N/A
7	Loss of weight	128	Nil	5 mg OM	5 mg OM	N/A
8	Increasing size of cervical nodes	233	340 (4 months post diagnosis)	40 mg OM	5 mg OM	N/A
9	Orbital mass, left optic neuropathy, salivary gland enlargement	52	Nil	60 mg OM	Nil	N/A
10	Obstructive jaundice, loss of weight	340	Nil	30 mg OM	20 mg OM	N/A
11	Obstructive jaundice	285	224 (3 years post diagnosis)	5 mg BD	5 mg EOD	N/A
12	Pancreatitis	126	Nil	Nil	Nil	N/A

OM: once in the morning

EOD: every other day

BD: twice daily